期刊文献+

CD4^+CD25^+调节性T细胞抑制小鼠自身免疫性甲状腺炎的发生 被引量:7

Study of CD4^+CD25^+ regulatory T cells in preventing adoptive transfer of experimental autoimmune thyroiditis
下载PDF
导出
摘要 目的 :研究CD4 + CD2 5 + Treg细胞对诱导小鼠实验性自身免疫性甲状腺炎 (EAT)的影响。方法 :磁性细胞分离器 (MACS)分离CD4 + CD2 5 + T细胞 ,通过体外细胞增殖试验和IFN γ的测定研究CD4 + CD2 5 + T细胞对CD4 + CD2 5 - T细胞的免疫抑制作用 ,同时通过过继转移试验研究CD4 + CD2 5 + T细胞抑制小鼠EAT的发生。结果 :MACS分离的CD4 + CD2 5 + T细胞纯度可达到 85 %~ 94 % ,特异性表达FoxP3基因 ,体外能明显抑制效应性T细胞的增殖和IFN γ的产生 ;将CD4 + CD2 5 + T细胞与病理性CD2 5 - T细胞共同注射正常小鼠 ,可抑制病理性T细胞诱导EAT的发生。结论 :CD4 + CD2 5 + Objective:To investigate the immunosuppression of mouse CD4^+CD25^+ regulatory T (Treg) cell.Methods:Mouse CD4^+CD25^+T cells were isolated by MACS (magnetic cell sorting)and identified by FCM(flow cytometry). Their suppression on the proliferation and the IFN-γ production of CD4^+CD25^-T effector cell were analyzed by cell proliferation assay and ELISA, respectively. The effects of CD4^+CD25^+T cells on the preventing experimental autoimmune thyroiditis were assessed by adoptive transfer.Results:CD4^+CD25^+T cell can be successfully classified by MACS with the purity reaching 85%~94% and specifically express the FoxP3 gene which is the ‘master control gene’ for Treg cells. These cells could suppressive the proliferation and the IFN-γ production of CD4^+CD25^-T effector cells in vitro. Co-transfer of CD4^+CD25^+T cell could prevent adoptive transfer of experimental autoimmune thyroiditis by pathogenic CD25^-T cell in vivo.Conclusion:CD4^+CD25^+ Treg contribute notably to regulation effector T cell and protection from autoimmune disease.
出处 《中国免疫学杂志》 CAS CSCD 北大核心 2005年第2期102-104,107,共4页 Chinese Journal of Immunology
基金 国家自然科学基金 (3 0 3 0 0 169) 江苏省自然科学基金 (BK2 0 0 44 0 5 )资助
关键词 CD4^+CD25^+T细胞 实验性自身免疫性甲状腺炎 免疫调节 小鼠 CD4^+CD25^+ T cell Experimental autoimmune thyroiditis Immune regulation Mice
  • 相关文献

参考文献8

  • 1王胜军,许化溪,刘恭植,柳龙图,江淑芳.树突状细胞对小鼠实验性自身免疫性甲状腺炎的作用[J].中国免疫学杂志,1999,15(7):294-295. 被引量:5
  • 2Sakaguchi S, Sakaguchi N, Asano M et al. Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor α-chains [J]. J Immunol, 1995; 155:1151-1164.
  • 3Bluestone J A, Abbas A K. Natural versus adaptive regulatory T cells [J]. Nat Rev Immunol,2003;3:253-257.
  • 4Nagler-Anderson C, Bhan A K, Podolsky D K et al. Control freaks: immune regulatory cells [J]. Nat Immunology,2004;5:119-122.
  • 5Wei W Z, Morris G P, Kong Y C. Anti-tumor immunity and autoimmunity: a balancing act of regulatory T cells [J]. Cancer Immunol Immunother,2004;53(2): 73-78.
  • 6Hori S, Nomura T, Sakaguchi S. Control of regulatory T cell development by the transcription factor Foxp3 [ J]. Science,2003 ;299:1057-1061.
  • 7Verginis P, Stanford M M, Carayanniotis. Delineation of five thyroglobulin T cell epitopes with pathogenic potential in experimental autoimmune thyroiditis [J] .J Immunol,2002; 169:5332-5337.
  • 8Thornton A M, Shevach E M. Suppressor effector function of CD4 + CD25 + immunoregulatory T cells is antigen nonspecific [J]. J Immunol,2000,164:183-190.

二级参考文献4

共引文献4

同被引文献122

  • 1兰玲,施秉银.促甲状腺素受体抗体检测的临床意义[J].国外医学(内分泌学分册),2005,25(1):42-44. 被引量:12
  • 2唐亚梅,陈志衡,唐爱国.Th1/Th2型细胞因子失衡与自身免疫性甲状腺疾病的关系研究[J].中国医师杂志,2005,7(7):876-878. 被引量:20
  • 3吴长有.Th17细胞:一种新的效应CD4^+T细胞亚群[J].细胞与分子免疫学杂志,2006,22(6):695-697. 被引量:36
  • 4党珊,施秉银.Graves病患者CD4^+CD25^+调节性T细胞的变化[J].中华内分泌代谢杂志,2007,23(3):253-254. 被引量:7
  • 5Brunkow ME, Jeffery EW, Hjerrild KA, et al. Disruption of a new forkhead/ forkhead/winged-helix protein, scurfin, results in the fatal lymphoprolifera- lymphoprolfferative disorder of the scurfy mouse. Nat Genet, 2001,27(1 ) :68-73.
  • 6Cao D, Borjesson O, Larsson P, et al. FOXP3 identifies regulatory CD25 bright CD4^+ T cells in rheumatic joints. Scand J Immunol, 2006,63(6) :444-452.
  • 7Bovenschen HJ, van Vlijmen-Willems IM, van de Kerkhof PC, et al. Identification of lesional CD4^+ CD25^+ Foxp3 ^+ regulatory T cells in Psoriasis. Dermatology, 2006, 213 (2) :111-117.
  • 8Alvarado-Sanchez B, Hemandez-Castro B, Portales-Perez D, et al. Regulatory T cells in patients with systemic lupus erythematosus. J Autoimmun, 2006, 27 (2) : 110-118.
  • 9Bassuny WM, lhara K, Sasaki Y, et al. A functional polymorphism in the promoter/enhancer region of the FOXP3/ Scurfin gene associated with type ldiabetes. Immunogenetics, 2003, 55(3):149-156.
  • 10Carlsson P, Mahlapuu M. Forkhead transcription factor:key players in development and metabolism. Dev Biol, 2002, 250 ( 1 ) : 1-23.

引证文献7

二级引证文献34

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部